Etidronic Acid
Back to searchMolecule Structure
Scientific Name
Etidronic Acid
Description of the Drug
Etidronic acid is a bisphosphonate drug that prevents osteoclastic bone resorption; used for the prevention and treatment of osteoporosis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01077
http://www.drugbank.ca/drugs/DB01077
Brand Name(s)
Not Available
Company Owner(s)
Allergan Pharmaceuticals International Ltd, Mylan Pharmaceuticals Inc, Mgi Pharma Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
ATP | SMALL MOLECULE | INHIBITOR | CHEMBL2366048 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL18607 | ||
PharmGKB | PA449548 | ||
Human Metabolome Database | HMDB0015210 | ||
DrugBank | DB01077 | ||
PubChem: Thomson Pharma | 14797598 | ||
PubChem | 3305 | ||
Mcule | MCULE-3037955142 | ||
LINCS | LSM-5508 | ||
Nikkaji | J7.915D | ||
PDBe | 911 | ||
BindingDB | 50115102 | ||
EPA CompTox Dashboard | DTXSID6023028 | ||
DrugCentral | 1098 | ||
Brenda | 5338 | ||
ChemicalBook | CB4719658 | ||
Guide to Pharmacology | 7184 | ||
rxnorm | ETIDRONATE DISODIUM | ETIDRONATE | ETIDRONIC ACID |
KEGG Ligand | C07736 | ||
ChEBI | 4907 | ||
ZINC | ZINC000003830813 |